Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
US pharma trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has presented research suggesting the Inflation Reduction Act (IRA) could 18 December 2023
The US business of South Korea's Celltrion Healthcare has secured approval for Zymfentra (infliximab-dyyb), a biosimilar of Johnson & Johnson’s Remicade. 24 October 2023